Prevalence of obesity and cardiovascular risk in patients with HIV/AIDS in Porto Alegre, Brazil

被引：23

作者：

Kroll, Andrea Francis ^{[1
,2
]}

Sprinz, Eduardo ^{[3
]}

Leal, Suzete Carbonell ^{[4
]}

Labrea, Maria da Graca ^{[2
]}

Setubal, Sergio ^{[1
]}

机构：

[1] Univ Fed Fluminense, Programa Posgrad Ciencias Med, BR-24033900 Niteroi, RJ, Brazil

[2] ADS, Porto Alegre, RS, Brazil

[3] HCPA, Porto Alegre, RS, Brazil

[4] IACHS, Porto Alegre, RS, Brazil

来源：

ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA | 2012年 / 56卷 / 02期

关键词：

Overweight; obesity; body mass index; HIV; acquired immunodeficiency syndrome; METABOLIC ABNORMALITIES; DISEASE RISK; HIV; OVERWEIGHT; INFECTION; THERAPY;

D O I：

10.1590/S0004-27302012000200007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective:The aim of this study was to discover the prevalence of overweight, obesity and cardiovascular risk in our HIV/AIDS outpatients according to sex, antiretroviral therapy and other variables. Subjects and methods: Patients underwent an anthropometric assessment. Body mass index and waist circumference were used to classify their nutritional status and their cardiovascular risk. Results: The majority of the 345 patients (58.8%) were males. Obesity was detected in 8.3% of them; 34.2% were overweight, and 5.2% malnourished. Near half of them (51.3%) had some cardiovascular risk, with increased risk in 24.6% of them, and substantially increased risk in 26.7% of them. Conclusions: Overweight and obesity were highly prevalent. Women were more frequently obese (OR = 3.53; IC 95%, 1.47 < OR < 8.69), and their cardiovascular risk was often higher (OR = 6.97; IC 95%, 4.16 < OR < 11.76). The prevalence of obesity and cardiovascular risk did not change according to antiretroviral therapy or other variables. Arq Bras Endocrinol Metab. 2012;56(2):137-41

引用

页码：137 / 141

页数：5

共 28 条

[1]

Amorosa V, 2005, JAIDS-J ACQ IMM DEF, V39, P557

[2]

[Anonymous], 2004, Serie A. Normas e Manuais Tecnicos

[3] Comparison Between the Framingham and Prospective Cardiovascular of Munster Scores for Risk Assessment of Coronary Heart Disease in Human Immunodeficiency Virus-Positive Patients in Pernambuco, Brazil [J].

Barros, Zoraya Medeiros ;

de Alencar Ximenes, Ricardo Arraes ;

Miranda-Filho, Democrito Barros ;

Pessoa Militao de Albuquerque, Maria De Fatima ;

Lacerda Melo, Heloisa Ramos ;

Carvalho, Erico Higino ;

Gelenske, Thais ;

Diniz, George ;

Bandeira, Francisco .

METABOLIC SYNDROME AND RELATED DISORDERS, 2010, 8 (06) :489-497

[4]

Coppini LZ, 2005, NUTR CLIN ADULTO

[5] Relations between cardiovascular risk estimates and subclinical atherosclerosis in naive HIV patients: results from the HERMES study [J].

De Socio, G. V. L. ;

Martinelli, C. ;

Ricci, E. ;

Orofino, G. ;

Valsecchi, L. ;

Vitiello, P. ;

Martinelli, L. ;

Quirino, T. ;

Maggi, P. ;

Bonfanti, P. .

INTERNATIONAL JOURNAL OF STD & AIDS, 2010, 21 (04) :267-272

[6] Abnormal body fat distribution and type of antiretroviral therapy as predictors of cardiovascular disease risk in HIV-infected patients [J].

Ena, J ;

Benito, C ;

Llácer, P ;

Pasquau, F ;

Amador, C .

MEDICINA CLINICA, 2004, 122 (19) :721-726

[7]

Farhi Lidia, 2008, J. Bras. Patol. Med. Lab., V44, P175, DOI 10.1590/S1676-24442008000300004

[8]

Galli M, 2002, J ACQ IMMUN DEF SYND, V29, P21, DOI 10.1097/00126334-200201010-00003

[9] Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy [J].

Hadigan, C ;

Meigs, JB ;

Corcoran, C ;

Rietschel, P ;

Piecuch, S ;

Basgoz, N ;

Davis, B ;

Sax, P ;

Stanley, T ;

Wilson, PWF ;

D'Agostino, RB ;

Grinspoon, S .

CLINICAL INFECTIOUS DISEASES, 2001, 32 (01) :130-139

[10] Nutrition Issues in the HIV-Infected Injection Drug User: Findings from the Nutrition for Healthy Living Cohort [J].

Hendricks, Kristy M. ;

Erzen, Heather D. ;

Wanke, Christine A. ;

Tang, Alice M. .

JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2010, 29 (02) :136-143

← 1 2 3 →